Translate Bio, A Sanofi Company - Similar companies

We find the nearest competitors to any company through our proprietary AI and database of millions of companies

Translate Bio, A Sanofi Company

Biotechnology Research · Lexington, Massachusetts
Website: www.translate.bio

Translate Bio is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to ... treat diseases caused by protein or gene dysfunction, or to prevent infectious diseases by generating protective immunity. Translate Bio is primarily focused on applying its technology to treat pulmonary diseases caused by insufficient protein production or where the reduction of proteins can modify disease. Translate Bio’s lead pulmonary candidate is being evaluated as an inhaled treatment for cystic fibrosis (CF) in a Phase 1/2 clinical trial. Additional pulmonary diseases are being evaluated in discovery-stage research programs that utilize a proprietary lung delivery platform. Translate Bio believes that mRNA can be delivered to target tissues via multiple routes of administration and, consequently, its technology may apply broadly to a wide range of diseases, including diseases that affect the liver. Translate Bio is also pursuing the development of mRNA vaccines for infectious diseases under a collaboration with Sanofi Pasteur. read more

Competitor Description Similarity

Loading..